Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Richard Scott Struthers currently holds 336,359 shares of Crinetics Pharmaceuticals, Inc. (CRNX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Richard Scott Struthers has been a net seller of CRNX stock. They have purchased $65.0K and sold $21.2M worth of shares.
Richard Scott Struthers's most recent insider trade was on Dec 18, 2025, when they sold 16,342 shares at $9.28 per share.
Richard Scott Struthers serves as Executive at Crinetics Pharmaceuticals, Inc. (CRNX). They have executed 51 insider transactions totaling $21.3M over their tenure at the company.
Richard Scott Struthers holds the position of Executive at Crinetics Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Richard Scott Struthers has shown a selling trading pattern, with $65.0K in total purchases and $21.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Richard Scott Struthers was on Nov 3, 2023, when they sold $6.1M worth of CRNX shares. This transaction involved 199,082 shares at $30.56 per share.
Richard Scott Struthers currently owns 336,359 shares of Crinetics Pharmaceuticals, Inc. (CRNX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Richard Scott Struthers's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Richard Scott Struthers has 51 Form 4 filings on record as an insider at Crinetics Pharmaceuticals, Inc..
Set alerts for Richard Scott Struthers and 40,000+ other insiders.